SUBSCRIBE
SUBSCRIBE
News   FDA

Pfizer Inc.'s Drug for Nerve Pain, Lyrica Gets Expanded Approval In Japan

October 29, 2010 | 
1 min read
Oct 28 (Reuters) - Japanese health regulators approved Pfizer Inc's (PFE.N) Lyrica to treat a type of nerve pain called peripheral neuropathic pain, Pfizer said on Thursday.
FDA Approvals Asia
Pfizer
MORE ON THIS TOPIC
Racing Cars at the finish line
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
 · 
4 min read
 · 
Tristan Manalac
Borrow money from friend, debt and loan, incentive or bonus payment, credit or lending concept, businessman hand giving money banknote to friend's hand.
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
 · 
1 min read
 · 
Annalee Armstrong
Female hand showing thumbs up gesture on blue background, art collage. Positive hand sign. Fashion collage in the style of Thumbs up magazine. Contemporary art. Modern design.
Approvals
Boehringer Wins Speedy Lung Cancer Approval Under Commissioner’s Priority Program
February 27, 2026
 · 
2 min read
 · 
Tristan Manalac